DekaBank Deutsche Girozentrale’s Verona Pharma VRNA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$359K	–	1362
2025 Q4	$359K	Hold	20,000	–	–	﹤0.01%	1056
2025 Q3	$2.09M	Hold	20,000	–	–	﹤0.01%	740
2025 Q2	$1.85M	Hold	20,000	–	–	﹤0.01%	756
2025 Q1	$1.21M	Hold	20,000	–	–	﹤0.01%	813
2024 Q4	$943K	Hold	20,000	–	–	﹤0.01%	885
2024 Q3	$567K	Hold	20,000	–	–	﹤0.01%	990
2024 Q2	$294K	Hold	20,000	–	–	﹤0.01%	1092
2024 Q1	$322K	Hold	20,000	–	–	﹤0.01%	1072
2023 Q4	$415K	Hold	20,000	–	–	﹤0.01%	1078
2023 Q3	$320K	Hold	20,000	–	–	﹤0.01%	1108
2023 Q2	$404K	Hold	20,000	–	–	﹤0.01%	1066
2023 Q1	$380K	Hold	20,000	–	–	﹤0.01%	1068
2022 Q4	$504K	Buy	+20,000	New	+$266K	﹤0.01%	1032

DekaBank Deutsche Girozentrale's VRNA Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Verona Pharma (VRNA) in Q1 2026, closing a stake of 20,000 shares — an estimated $359K sold.

DekaBank Deutsche Girozentrale first reported a position in VRNA in Q4 2022 and held it in 13 quarters. The position peaked at $2.09M in Q3 2025. 0 funds tracked by Wall St. Rank hold VRNA as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Verona Pharma position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 20,000 Verona Pharma shares in Q1 2026, an estimated $359K.
DekaBank Deutsche Girozentrale first reported a position in Verona Pharma in Q4 2022 and held it in 13 quarters.
DekaBank Deutsche Girozentrale's Verona Pharma position peaked at $2.09M in Q3 2025.
0 funds tracked by Wall St. Rank held Verona Pharma as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.